The latest X-ray technology goes beyond foreign body detection, ensuring each dose is right first time – every time.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

The highlights of the trade show and its conference agenda - day 3

How the pharma industry can help tackle the opioid crisis and advance treatments

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

The highlights of the trade show and its conference agenda - day 2

The highlights of the trade show and its conference agenda - day 1

Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.